OxyContin
Coverage of OxyContin in the Nexus archive.
- Super-potent synthetic opioids called nitazenes are spreading across the U.S.
Super-potent synthetic opioids called nitazenes are spreading across the U.S. Ashley Delgado, who had high academic achievements and dreams of becoming a doctor, developed an addiction starting with OxyContin in her mid-20s, progressing through methamphetamine, heroin, and fentanyl.
- Berkeley County Man Sentenced to 5 Years in Federal Prison for Distribution of Fentanyl that Resulted in Death
Levi Phillip Miles, 48, of Goose Creek, was sentenced to five years in federal prison for conspiracy to possess with intent to distribute fentanyl and oxycontin, and distribution of fentanyl that caused the death of a local lawyer. The case involved drug-related charges leading to a fatal outcome.
- Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case
Purdue Pharma, the maker of OxyContin, is being dissolved and replaced by a new company focused on addressing the opioid crisis as part of a legal settlement. A federal judge approved a criminal sentence to resolve a DOJ investigation, finalizing the settlement.
- Maker of OxyContin set to dissolve after judge approves criminal sentence
Purdue Pharma, the maker of OxyContin, is set to dissolve after a judge approved a criminal sentence as part of a massive legal settlement resolving thousands of lawsuits.
- “A Punch in the Gut”: After Years of Waiting, Many Opioid Victims Will Be Shut Out of Purdue Settlement
Purdue Pharma's $7.4 billion bankruptcy plan, approved in 2024, excludes tens of thousands of opioid victims who originally filed claims, including Mary Jannotta and her family, whose son died from an overdose. The new settlement slashes payments, imposes stricter eligibility requirements, and removes the option to use sworn affidavits to prove Purdue drug use, impacting victims like those who lost loved ones to overdoses.
- Purdue Pharma expected to forfeit $225m as sentence in criminal opioids case
Purdue Pharma is set to forfeit $225 million to the US Justice Department as part of a 2020 settlement resolving federal civil and criminal investigations over its role in the opioid crisis. The Sackler family will pay state, local, and tribal governments, individual victims, and others under the agreement.
- Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
Purdue Pharma is set to be sentenced to a $225 million criminal penalty, clearing the way for a $7 billion settlement from the Sackler family to address the opioid crisis. The settlement, approved in 2020, resolves federal and state lawsuits over Purdue's role in aggressively marketing OxyContin, contributing to the opioid epidemic.